Avenue Therapeutics, Inc.
ATXI
$0.7727
-$0.0003-0.04%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.26% | 37.97% | -778.13% | 21.67% | 113.13% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.08% | -68.52% | 142.86% | -100.49% | -147.23% |
| Change in Net Operating Assets | -179.63% | -52.35% | 137.32% | -132.99% | 86.16% |
| Cash from Operations | -28.23% | 27.79% | -34.25% | -161.42% | 80.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 50.00% |
| Cash from Investing | -- | -- | -- | 100.00% | 50.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.05% | -4.62% | 28.34% | 604.55% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -73.08% | -722.54% | 200.00% | -- |
| Cash from Financing | -85.75% | -12.20% | 14.83% | 723.80% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -234.61% | 22.25% | -13.01% | 215.04% | 78.84% |
